Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum-Reference-Cited by-同舟云学术

Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum

Published:1990-11 Issue:6 Volume:12 Page:587-603
ISSN:0141-9838
Container-title:Parasite Immunology
language:en
Short-container-title:Parasite Immunol

Author:

CARTER RICHARD,GRAVES PATRICIA M.,KEISTER DAVID B.,QUAKYI ISABELLA A.

Publisher

Wiley

Subject

Immunology,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3024.1990.tb00990.x/fullpdf

Reference25 articles.

1. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate

2. Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies

3. Plasmodium gallinaceum: Transmission-blocking immunity in chickens

4. A. Foo, R. Carter, C. Lambros, P.M. Graves, I.A. Quakyi, G.A.T. Targett, and T. Ponnudurai (1990 ) Conserved and variant epitopes of target antigens of transmission-blocking antibodies inPlasmodium falciparum. American Journal of Tropical Medicine and Hygiene(submitted for publication).

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax;Vaccine;2024-08

2. The global transcriptome of Plasmodium falciparum mid-stage gametocytes (stages II–IV) appears largely conserved and gametocyte-specific gene expression patterns vary in clinical isolates;Microbiology Spectrum;2023-10-17

3. Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine;npj Vaccines;2023-02-18

4. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes;Immunity;2023-02

5. Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies;Nature Communications;2022-09-24